Navigation Links
Children's National researcher receives ACCP Distinguished Investigator Award
Date:9/8/2008

The American College of Clinical Pharmacology (ACCP) has awarded John van den Anker, MD, PhD, director of Pediatric Clinical Pharmacology at Children's National Medical Center, its annual Distinguished Investigator Award.

Dr. van den Anker, a neonatologist by training, receives this award for "his sustained and prolific contributions to pediatric clinical pharmacology," according to the ACCP.

The Distinguished Investigator Award is given yearly and recognizes superior scientific expertise and accomplishments by a senior investigator, usually involving a distinct area of research in basic or clinical pharmacology for which the individual is internationally known.

Dr. van den Anker is the director of Pediatric Clinical Pharmacology at Children's National Medical Center, and also serves as associate director of Children's Research Institute's Center for Clinical and Community Research. He is professor of Pediatrics, Pharmacology, and Physiology at the George Washington University School of Medicine and Health Sciences, and holds the Evan and Cindy Jones Chair in Pediatric Clinical Pharmacology at Children's National. He has received several major awards from the National Institutes of Health and has published more than 150 peer reviewed papers in the field of neonatal and pediatric clinical pharmacology. He also served as the president of the European Society of Developmental, Perinatal, and Pediatric Pharmacology from 2006-2008.


'/>"/>

Contact: Jennifer Leischer
jleische@cnmc.org
202-476-4500
Children's National Medical Center
Source:Eurekalert

Page: 1

Related biology news :

1. Corporate Safe Specialists Launches International Sales Efforts
2. New chemical radar among national security innovations in ACS podcast
3. International team reveals first prognosticator of survival in aggressive cancer
4. White House announces 2007 National Medal of Science laureates
5. National security remedies among topics at surveillance confab
6. Duke Medicine physician-scientist receives National Medal of Science
7. National Research Council report on security at federally managed dams
8. Food, health get top billing at national chemistry meeting
9. Childrens national co-leads nationwide study of landmark sickle cell treatment
10. Story tips from the US Department of Energys Oak Ridge National Laboratory, August 2008
11. [video] Michael DePasquale, CEO of BIO-key International, Inc., Discusses Q2 2008 Revenue Growth on WallSt.nets 3-Minute Press Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2015)... YORK , Feb. 24, 2015 This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided for the ... provided for these markets. Market data and analytics are derived ...
(Date:2/23/2015)... , Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62114357 for DISTRIBUTED VOICE DIRECTED ... NXT-ID introduces a new groundbreaking payment method. Payment accounts ... account may only be accessed if both the speech ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT Genomics ... that aims to transform cancer genomic information into ... the company has raised US$ 8 million in the ... in Taipei, Taiwan , ACT ... ACTOnco™. With the aim to implement next generation ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2
... scientists have found a way to boost current industry capabilities ... coli 0157:H7 cells that may live undetected on spinach ... we can reduce the total number of foodborne pathogenic bacteria ... I professor of food science and human nutrition. According ...
... This press release is available in German . ... the most fascinating species of the Galapagos archipelago, treks ... the Max Planck Institute for Ornithology in Radolfzell, together ... and modern 3D acceleration measurements to find out that ...
... research delegation, Lund University and His Excellency the Ambassador of ... to a seminar dedicated to Swedish research on 5 December ... Brazil and present the latest research from Lund University. We ... decision makers, corporate organisations, as well as former and future ...
Cached Biology News:Safer spinach? Scientist's technique dramatically reduces E. coli numbers 2Galapagos tortoises are a migrating species 2Galapagos tortoises are a migrating species 3Swedish research useful to Brazilian society, presented by Lund University in São Paulo on 5 Dec. 2012 2Swedish research useful to Brazilian society, presented by Lund University in São Paulo on 5 Dec. 2012 3
(Date:2/26/2015)... VIEW, Calif. , Feb. 26, 2015  23andMe, ... of Kate Black as Privacy Officer and ... federal, and state privacy laws as well as health ... regulatory team, she will be responsible for reviewing, updating ... customers in the U.S. and abroad. She joined the ...
(Date:2/26/2015)... Feb. 26, 2015   Synageva BioPharma Corp. ... company developing therapeutic products for rare disorders, today ... 2015 goals, other key objectives, and financial guidance.  ... today at 4:30 p.m. EST to review the ... To participate in today,s call by telephone, please ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015 Protiviti ... the latest version of the Governance Portal , ... governance, risk and compliance (GRC) tasks across multiple business ... been updated to help customers better align their controls ... the Treadway Commission ) requirements. In response to client ...
(Date:2/26/2015)... February 26, 2015 The Movement for ... to support life extension technologies and awareness. The event ... Coordinated Time, on March 21st 2015, in a live ... , Eric Schulke, Founder of MILE, says, “Our lives ... urgency. The Movement for Indefinite Life Extension is raising ...
Breaking Biology Technology:23andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3
... a leader in human embryonic stem cell derived products, ... to produce induced pluripotent stem cells with Open Biosystems ... http://www.newscom.com/cgi-bin/prnh/20080819/CLTU003LOGO )In the spirit ... the complete and fully validated induced pluripotent stem cell ...
... Phase 2 MDCT Sub-study to be Released Concurrent with ... (Nasdaq: VIAP ), a biotechnology company focused ... cardiovascular and metabolic disease, today announced that an abstract ... has been accepted for a poster presentation at the ...
... today announced that it will host a conference call ... (FDA) approval of IXIARO(R), a new vaccine for the ... use of Intercell,s vaccine - the only such product ... adult travelers and military personnel who visit or are ...
Cached Biology Technology:ArunA Biomedical Announces Co-development of Fully Validated Induced Pluripotent Stem Cell Kit 2VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009 2VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009 3VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009 4Intercell to Host Conference Call and Webcast Today on FDA Approval of IXIARO(R) Japanese Encephalitis Vaccine 2Intercell to Host Conference Call and Webcast Today on FDA Approval of IXIARO(R) Japanese Encephalitis Vaccine 3
Mouse monoclonal [002-49] to C1s ( Abpromise for all tested applications). entrezGeneID: 716 SwissProtID: P09871...
Goat polyclonal to HSPC150 ( Abpromise for all tested applications). entrezGeneID: 29089...
Oct 2 Immunogen: Full length human protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse monoclonal [3B6] to HSV1 + HSV2 ICP5 Major Capsid Protein ( Abpromise for all tested applications)....
Biology Products: